文献速递头颈部肿瘤放疗

鼻咽癌根治性放疗后获得性鼻腔狭窄闭锁的正常组织并发症概率模型开发与验证

Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
PubMed 文献 · Radiother Oncol · 2021-04-09

本研究基于548例接受根治性放疗的鼻咽癌患者回顾性队列,随机分为训练组和验证组,采用LASSO回归筛选变量,建立并验证了预测获得性鼻腔狭窄闭锁(ANCSA)的多因素NTCP模型和列线图。结果显示ANCSA发生率为24.1%,中位检出时间2.8个月,模型在训练组和验证组ROC曲线下面积分别为0.79和0.73,校准良好。

要点

  • 鼻咽癌根治性放疗后ANCSA发生率为24.1%,中位检出时间2.8个月。
  • 模型纳入后鼻孔侵犯、低白细胞计数、高C反应蛋白、高血清淀粉样蛋白A和高V70Gy五个预测因子。
  • 模型区分度训练组AUC=0.79,验证组AUC=0.73,校准测试良好。

核心结论

  • 成功开发并验证了可早期预测鼻咽癌根治性放疗后ANCSA的NTCP模型,有助于临床医生在随访开始前评估风险并及时管理该并发症。

研究设计与样本

  • 回顾性队列研究,纳入548例接受根治性放疗的鼻咽癌患者,随机分为训练组和验证组。
  • 在训练组中采用LASSO回归从临床和剂量学特征中筛选变量,建立多因素NTCP模型和列线图。
  • 使用ROC曲线和校准测试分别在两组中检验区分度和校准度。

主要发现

  • 548例患者中132例(24.1%)发生ANCSA,治疗后中位检出时间为2.8个月(范围0.0-57.7个月)。
  • 基于训练组365例患者筛选出5个预测因子:后鼻孔侵犯、低白细胞计数、高C反应蛋白水平、高血清淀粉样蛋白A水平和高V70Gy(鼻腔)。
  • 模型区分度:训练组ROC曲线下面积=0.79(95%CI: 0.73-0.84),验证组=0.73(95%CI: 0.64-0.82)。
  • 校准度:训练组E-max=0.069,E-avg=0.015,p=0.977;验证组E-max=0.057,E-avg=0.032,p=0.747。

关键数值与推荐

  • ANCSA发生率为24.1%(132/548),中位检出时间2.8个月(范围0.0-57.7个月)。
  • 预测因子包括后鼻孔侵犯、低白细胞计数、高C反应蛋白、高血清淀粉样蛋白A和高V70Gy(鼻腔)。
  • 训练组AUC=0.79(95%CI: 0.73-0.84),验证组AUC=0.73(95%CI: 0.64-0.82)。
  • 校准测试训练组p=0.977,验证组p=0.747。

临床怎么用

  • 该NTCP模型可用于鼻咽癌根治性放疗后患者在随访开始前评估ANCSA风险,辅助及时管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Curative radiotherapy for nasopharyngeal carcinoma (NPC) can lead to acquired nasal cavity stenosis and atresia (ANCSA). As the first study to investigate risk factors of ANCSA in a large cohort of NPC patients, this article aims to develop and validate a multivariate normal tissue complication probability (NTCP) model to predict the development of ANCSA and to establish a nomogram for clinical use. METHODS AND MATERIALS: The retrospective cohort was comprised of 548 NPC patients treated with radical radiotherapy. The cohort was randomly divided into training and validation groups. Least absolute shrinkage and selection operator regression was performed for variable selection from the clinical and dosimetric characteristics in the training group. A multivariate NTCP model and a nomogram were established for the prediction of ANCSA development. Discrimination and calibration were tested using receiver operating characteristic (ROC) curves and calibration tests, respectively, for both groups. RESULTS: ANCSA was observed in 132 (24.1%) of 548 patients with NPC who underwent radical radiotherapy. The median time to ANCSA detection after treatment was 2.8 months (range, 0.0-57.7 months). Five potential predictors, including choanal invasion, low white blood cell count, high C-reactive protein level, high serum amyloid A level, and high V70Gy of the nasal cavity, were selected to develop the NTCP model based on 365 patients in the training group. The model had a fairly good discriminative power according to the ROC analysis in both the training (area under ROC curve = 0.79, 95%CI: 0.73-0.84) and validation (0.73, 0.64-0.82) groups. The calibration power was tested using the calibration test in the training (E-max = 0.069, E-avg = 0.015, p = 0.977) and validation (E-max = 0.057, E-avg = 0.032, p = 0.747) groups. CONCLUSIONS: We developed and successfully validated an NTCP model for early prediction of ANCSA in patients with NPC after radical radiotherapy. This could help clinicians assess the risk of ANCSA before the initiation of follow-ups and ensure appropriate and timely management of this complication.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Yan JJ, Guo SS, Lin DF, et al. Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma. Radiother Oncol. 2021. PMID: 33839205. doi:10.1016/j.radonc.2021.03.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。